MWC investigators found new cancer therapy start-up TAMORx
3 June 2022
MWC investigators Dr Joanna Mathy and Prof Rod Dunbar lead new cancer therapy drug research company, TAMORx, based upon MWC supported research and facilities.
MWC researchers identify novel drug target for TB
14 May 2020
Several researchers from the Maurice Wilkins Centre are co-authors on a recent paper reporting a novel mechanism for controlling the synthesis of essential vitamin K2 in the bacterial pathogen that causes tuberculosis.